Skip to main content
. 2016 Feb 11;16:90. doi: 10.1186/s12885-016-2136-1

Fig. 2.

Fig. 2

Comparison of chromosomic aberrations in primary tumor (PR) and in its Patient derived xenograft (PDX). In red, the loss regions, in blue the gain regions